Vitamin D: Present and future;Vitamina D: Presente y futuro

Revista Clinica Espanola

Volumn 214, Issue 7, 2014, Pages 396-402

  Varsavsky, M ^a   Alonso, G ^b   Garcia Martin A ^c  

^a Hospital Sant Pau i Santa Tecla   (Spain)

^b Servicio de Endocrinología   (Argentina)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Fractures Stress; Osteoporosis; Osteoporotic Fractures; Vitamin D; Vitamin D Deficiency

Indexed keywords

CALCIDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; MINERAL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BONE METABOLISM; BONE MINERAL; DRUG EFFECT; FRACTURE; HUMAN; RISK FACTOR; SENESCENCE; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84922476117     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2014.04.003     Document Type: Article

References (45)

1. Sánchez Ripollés JM. Breve visión histórica de la vitamina D.Reemo. 2005;14:20
2. Holick MF. Sunlight and vitamin D for bone health and preventionof autoimmune disease, cancers and cardiovascular disease. AmJ Clin Nutr. 2004;80 Suppl 6:S1678-88
3. Bhan A, Rao AD, Rao DS. Osteomalacia as a result of vitamin Ddeficiency. Endocrinol Metab Clin N Am. 2010;39:321-31
4. Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, HabibRH, et al. 25-hydroxyvitamin D assay variations and impacton clinical decision making. J Clin Endocrinol Metab. 2012;97:835-43
5. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L,Sigurdsson G. Relationship between serum parathyroid hor-mone levels, vitamin D sufficiency, and calcium intake. JAMA.2005;294:2336-41
6. Binkley N, Krueger D. Evaluation and correction of low vitaminD status. Curr Osteoporos Rep. 2008;6:95-9
7. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ,Vieth R. Estimates of optimal vitamin D status. Osteoporos Int.2005;16:713-6
8. Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship bet-ween vitamin D, parathyroid hormone, and bone health. J ClinEndocrinol Metab. 2011;96:436-46
9. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T,Dawson-Hughes B. Estimation of optimal serum concentrationsof 25-hydroxyvitamin D for multiple health outcomes. Am J ClinNutr. 2006;84:18-28
10. Hanley DA, Cranney A, Jones G. Vitamin D in adult health anddisease: A review and guideline statement from OsteoporosisCanada. CMAJ. 2010;182:610-8
11. González Macías J, Guañabens Gay N, Gómez Alonso C, delRío Barquero L, Muñoz Torres M, Delgado M, et al. Guías depráctica clínica en la osteoporosis posmenopáusica, glucocorti-coidea y del varón. Sociedad Española de Investigación Ósea ydel Metabolismo Mineral. Rev Clin Esp. 2008;208 Supl 1:1-24
12. Dawson-Hughes B, Mithal A, Bonjour J-P. IOF position statement:vitamin D recommendations for older adults. Osteoporos Int.2010;21:1151-4
13. IOM report on calcium and vitamin D. Washington, DC: Insti-tute of Medicine, 2010. [consultado 10 Abr 2014] Disponible en:http://www.nap.edu/catalog.php?recordid=1305014.
14. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y,Wang TJ, et al. Vitamin D and musculoskeletal health, cardio-vascular disease, autoimmunity and cancer: Recommendationsfor clinical practice. Autoimmun Rev. 2010;11:709-15
15. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Han-ley DA, Robert P, et al. Evaluation, treatment, and preventionof vitamin D deficiency: An Endocrine Society Clinical PracticeGuideline. J Clin Endocrinol Metab. 2011;96:1911-30
16. Gómez de Tejada Romero MJ, Sosa Henríquez M, Del Pino Mon-tes J, Jódar Gimeno E, Quesada Gómez JM, Cancelo HidalgoMJ, et al. Documento de posición sobre las necesidades yniveles óptimos de vitamina D. Rev Osteoporos Metab Miner.2011;3:53-64
17. Lips P, van Schoor NM. The effect of vitamin D on bone and osteo-porosis. Best Pract Res Clin Endocrinol Metab. 2011;25:585-91
18. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Die-trich T, Dawson-Hughes B. Fracture prevention with vitaminD supplementation: A meta-analysis of randomized controlledtrials. JAMA. 2005;293:2257-64
19. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschue-ren P, Haentjens D. Need for additional calcium to reduce therisk of hip fracture with vitamin D supplementation: evidencefrom a comparative meta-analysis of randomized controlledtrials. J Clin Endocrinol Metab. 2007;92:1415-23
20. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements onbone mineral density: A systematic review and meta-analysis.Lancet. 2014;383:146-55
21. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of cal-cium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years andolder: A meta-analysis. Lancet. 2007;370:657-66
22. Moyer VA, U.S. Preventive Services Task Force.AT Vitamin D andcalcium supplementation to prevent fractures in adults: U.S.Preventive Services Task Force Recommendation Statement.Ann Intern Med. 2013;158:691-6
23. Bischoff-Ferrari HA, Willet WC, Orav EJ, Lips P, Meunier PJ,Lyons RAA. Pooled analysis of vitamin D dose requirements forfracture prevention. N Engl J Med. 2012;367:40-9
24. Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, FioreCE, et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int. 2009;20:239-44
25. Ceglia L. Vitamin D and its role in skeletal muscle. Curr OpinClin Nutr Metab Care. 2009;12:628-33
26. Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cho-lecalciferol (vitamin D3) on the risk of fall and fracture: Ameta-analysis. Q J Med. 2007;100:185-92
27. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE,Stuck AE, Theiler R, et al. Fall prevention with supplementaland active forms of vitamin D: A meta-analysis of randomisedcontrolled trials. BMJ. 2009;339:b3692
28. Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S,Cumming RG, et al. Interventions for preventing falls in olderpeople living in the community. Cochrane Database Syst Rev.2009;15:CD007146
29. Holick MF. Vitamin D: extraskeletal health. Rheum Dis Clin NorthAm. 2012;38:141-60
30. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kesten-baum B, et al., for theWomen's Health Initiative Investigators.Calcium plus vitamin D supplementation and the risk of inci-dent diabetes in the Women's Health Initiative. Diabetes Care.2008;31:701-7
31. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brun-ner RL, O'Sullivan MJ, et al., for the Women's Health InitiativeInvestigators. Calcium plus vitamin D supplementation and therisk of colorectal cancer. N Engl J Med. 2006;354:684-96
32. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, HeaneyRP. Vitamin D and calcium supplementation reduces cancer risk:results of a randomized trial. Am J Clin Nutr. 2007;85:1586-91
33. Wang L, Manson JE, Song Y, Sesso HD. Systematic review:Vitamin D and calcium supplementation in prevention of car-diovascular events. Ann Intern Med. 2010;152:315-23
34. Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDo-nald AM, Pant PR, et al., RECORD Trial Group. Long-termfollow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD trial). JClin Endocrinol Metab. 2012;97:614-22
35. Perna L, Schöttker B, Holleczek B, Brenner H. Serum25-hydroxyvitamin D and incidence of fatal and nonfatalcardiovascular events: A prospective study with repeated mea-surements. J Clin Endocrinol Metab. 2013;98:4908-15
36. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J,Simonetti RG, et al. Vitamin D supplementation for preven-tion of mortality in adults. Cochrane Database Syst Rev. 2011;7.CD007470
37. Smith H, Anderson F, Raphael H, Maslin P, Crozier S, CooperC. Effect of annual intramuscular vitamin D on fracture riskin elderly men and women-A population-based, randomized,double-blind, placebo-controlled trial. Rheumatology (Oxford).2007;46:1852-7
38. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, KotowiczMA, Young D, et al. Annual high-dose oral vitamin D and fallsand fractures in older women: A randomized controlled trial.JAMA. 2010;303:1815-22
39. Autier P, Gandini S, Mullie P. A systematic review: influenceof vitamin D supplementation on serum 25-hydroxyvitamin Dconcentration. J Clin Endocrinol Metab. 2012;97:2606-13
40. Bauer DC. Calcium supplements and fracture prevention. NEJM.2013;369:1537-43
41. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decrea-sed bioavailability of vitamin D in obesity. Am J Clin Nutr.2000;72:690-3
42. Torregrosa JV, Bover J, Cannata Andia J, Lorenzo V, de Fran-cisco ALM, Martinez I, et al. Recomendaciones de la SociedadEspañola de Nefrología para el manejo de las alteraciones delmetabolismo óseo-mineral en los pacientes con enfermedadrenal crónica (SEN). Nefrología. 2011;31 Suppl.1:3-32
43. Garcia Dolade N, Cereza García G, Madurga Sanz M, MonteroCorominas D. Risk of hypercalcemia and hipervitaminosis Dinduced by calcifediol. Review of cases reported to the SpanishPharmacovigilance System. Med Clin (Barc). 2013;141:88-9
44. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D withor without calcium supplementation for prevention of cancerand fractures: An updated meta-analysis for the U.S. PreventiveServices Task Force. Ann Intern Med. 2011;155:827-38
45. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE,et al. The nonskeletal effects of vitamin D: An Endocrine Societyscientific statement. Endocrine Reviews. 2012;33:456-92.